1. Home
  2. GCTS vs CRDL Comparison

GCTS vs CRDL Comparison

Compare GCTS & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GCT Semiconductor Holding Inc.

GCTS

GCT Semiconductor Holding Inc.

HOLD

Current Price

$1.29

Market Cap

82.1M

Sector

Finance

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.01

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCTS
CRDL
Founded
1998
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.1M
97.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GCTS
CRDL
Price
$1.29
$1.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$3.50
$9.00
AVG Volume (30 Days)
127.8K
660.3K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,893,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,205.88
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$0.77
52 Week High
$2.76
$1.59

Technical Indicators

Market Signals
Indicator
GCTS
CRDL
Relative Strength Index (RSI) 37.85 48.53
Support Level $1.29 $0.88
Resistance Level $1.49 $1.12
Average True Range (ATR) 0.08 0.07
MACD -0.01 0.00
Stochastic Oscillator 4.00 58.09

Price Performance

Historical Comparison
GCTS
CRDL

About GCTS GCT Semiconductor Holding Inc.

GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: